Veracyte Inc (VCYT)
38.94
-0.26
(-0.66%)
USD |
NASDAQ |
Nov 21, 16:00
38.95
+0.01
(+0.03%)
After-Hours: 20:00
Veracyte Shareholders Equity (Quarterly): 1.176B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.176B |
| June 30, 2024 | 1.133B |
| March 31, 2024 | 1.119B |
| December 31, 2023 | 1.044B |
| September 30, 2023 | 1.054B |
| June 30, 2023 | 1.083B |
| March 31, 2023 | 1.081B |
| December 31, 2022 | 1.075B |
| September 30, 2022 | 1.048B |
| June 30, 2022 | 1.064B |
| March 31, 2022 | 1.085B |
| December 31, 2021 | 1.097B |
| September 30, 2021 | 1.107B |
| June 30, 2021 | 971.18M |
| March 31, 2021 | 974.23M |
| December 31, 2020 | 421.23M |
| September 30, 2020 | 422.72M |
| June 30, 2020 | 226.15M |
| March 31, 2020 | 230.42M |
| December 31, 2019 | 239.46M |
| September 30, 2019 | 231.02M |
| June 30, 2019 | 224.24M |
| March 31, 2019 | 83.77M |
| December 31, 2018 | 79.76M |
| Date | Value |
|---|---|
| September 30, 2018 | 79.42M |
| June 30, 2018 | 25.81M |
| March 31, 2018 | 30.01M |
| December 31, 2017 | 37.22M |
| September 30, 2017 | 42.82M |
| June 30, 2017 | 47.84M |
| March 31, 2017 | 53.35M |
| December 31, 2016 | 59.58M |
| September 30, 2016 | 30.00M |
| June 30, 2016 | 33.75M |
| March 31, 2016 | 43.31M |
| December 31, 2015 | 51.25M |
| September 30, 2015 | 57.81M |
| June 30, 2015 | 65.09M |
| March 31, 2015 | 35.08M |
| December 31, 2014 | 41.37M |
| September 30, 2014 | 48.28M |
| June 30, 2014 | 45.02M |
| March 31, 2014 | 50.29M |
| December 31, 2013 | 56.44M |
| September 30, 2013 | 2.447M |
| June 30, 2013 | 8.412M |
| December 31, 2012 | 4.901M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
226.15M
Minimum
Jun 2020
1.176B
Maximum
Sep 2024
882.55M
Average
1.059B
Median
Shareholders Equity (Quarterly) Benchmarks
| Fonar Corp | 168.69M |
| XWELL Inc | 6.304M |
| ProPhase Labs Inc | 38.13M |
| Applied DNA Sciences Inc | 12.39M |
| OncoCyte Corp | 9.711M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.275B |
| Total Liabilities (Quarterly) | 98.98M |
| Current Ratio | 5.075 |